Southern Community Laboratories applies to acquire Medlab South
Commerce Commission receives application from Southern Community Laboratories seeking to acquire 100% of the shares in Medlab South.
The Commerce Commission has received an application from Southern Community Laboratories Ltd (SCL) seeking clearance to acquire 100% of the shares in Medlab South Limited.
SCL, which is 100% owned by Healthscope New Zealand Limited, provides pathology services in various regions in the country, including contracted services to the Canterbury and Southern District Health Boards (DHB).
From 1 April 2012, Southern Community Laboratories is contracted for the next five years to be the sole provider of community pathology services for the Canterbury DHB.
Medlab South, a wholly owned subsidiary of Sonic Healthcare New Zealand Limited, is the sole provider of all community and hospital pathology services to the South Canterbury and Nelson/Malborough DHBs. It has provided community pathology-testing services to the Canterbury DHB but will cease those services on 31 March 2012 when the contract finally expires.
The clearance application affects the provision of contracted community and hospital pathology services to the South Canterbury and Nelson/Malborough DHBs when those contracts expire.
In considering the application, the Commission’s role is to determine whether the acquisition has the effect to substantially lessening competition in a market.
NBR Staff
Fri, 02 Mar 2012
Fri, 02 Mar 2012
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Southern Community Laboratories applies to acquire Medlab South
19162